Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects

Determine the benefit of oral vancomycin therapy for Primary Sclerosing Cholangitis.

Stanford Investigator(s)

  • Shamita B. Shah, MD

CONTACT INFORMATION

Primary Contact:
Ken Cox, MD
(650) 721-2250